XML 34 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of stock based compensation expense

The stock-based compensation expense included in the Company's consolidated financial statements for the three and nine-months ended September 30, 2018 and October 1, 2017 was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

2018

 

 

October 1,

2017

 

 

September 30,

2018

 

 

October 1,

2017

 

Cost of revenue

 

$

30

 

 

$

32

 

 

$

99

 

 

$

85

 

Research and development

 

 

220

 

 

 

151

 

 

 

610

 

 

 

424

 

Selling, general and administrative

 

 

266

 

 

 

212

 

 

 

718

 

 

 

551

 

Total costs and expenses

 

$

516

 

 

$

395

 

 

$

1,427

 

 

$

1,060

 

 

Summary of the activity in the shares available for grant under the 2009 plan

The following table summarizes the activity in the shares available for grant under the 2009 Plan during the nine months ended September 30, 2018:

 

 

 

Shares

Available for Grant

 

 

 

(in thousands)

 

Balance at December 31, 2017

 

 

3,899

 

Authorized

 

 

4,000

 

RSUs granted

 

 

(1,389

)

RSUs forfeited or expired

 

 

151

 

Options forfeited

 

 

50

 

Balance at September 30, 2018

 

 

6,711

 

 

Summary of stock options outstanding and stock option activity under the 1999 plan and the 2009 plan, and the related weighted average exercise price

The following table summarizes stock options outstanding and stock option activity under the 2009 Plan, and the related weighted average exercise price, for the nine months of 2018:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

(in thousands)

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Balance outstanding at December 31, 2017

 

 

3,558

 

 

$

2.09

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(50

)

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(5

)

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding at September 30, 2018

 

 

3,503

 

 

$

2.08

 

 

 

3.64

 

 

$

131

 

Exercisable at September 30, 2018

 

 

3,116

 

 

$

2.22

 

 

 

3.11

 

 

$

80

 

Vested and expected to vest at September 30, 2018

 

 

3,441

 

 

$

2.10

 

 

 

3.56

 

 

$

122

 

 

Summary of activity for RSUs and PRSUs

A summary of activity for the Company's RSUs for the nine months ended September 30, 2018 and information regarding RSUs outstanding and expected to vest as of September 30, 2018 is as follows:

 

 

 

RSUs & PRSUs Outstanding

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

 

 

 

Nonvested at December 31, 2017

 

 

2,363

 

 

$

1.54

 

Granted

 

 

1,388

 

 

 

1.50

 

Vested

 

 

(827

)

 

 

1.28

 

Forfeited

 

 

(150

)

 

 

 

Nonvested at September 30, 2018

 

 

2,774

 

 

$

1.59

 

 

Summary of the fair value of rights issued pursuant to ESPP

The fair value of rights issued pursuant to the Company's 2009 ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

2018

 

 

October 1,

2017

 

 

September 30,

2018

 

 

October 1,

2017

 

Expected term (months)

 

 

6.00

 

 

 

6.0

 

 

 

6.00

 

 

 

6.00

 

Risk-free interest rate

 

 

2.09

%

 

 

1.02

%

 

 

2.09

%

 

 

1.02

%

Volatility

 

 

44.76

%

 

 

49.71

%

 

 

44.76

%

 

 

49.71

%

Dividend yield